[(Improved detection,would facilitate,assessment,1.0), (Improved detection,would facilitate,diagnosis,1.0), (detection,would facilitate,assessment,1.0), (detection,would facilitate,diagnosis of response to treatment,1.0), (Improved detection,would facilitate,diagnosis of response,1.0), (detection,would facilitate,diagnosis,1.0), (Improved detection,would facilitate,diagnosis of response to treatment,1.0), (Improved detection,would facilitate,surveillance,1.0), (detection,would facilitate,surveillance,1.0), (detection,would facilitate,diagnosis of response,1.0)][(Improved detection,would facilitate,assessment,1.0), (Improved detection,would facilitate,diagnosis,1.0), (detection,would facilitate,assessment,1.0), (detection,would facilitate,diagnosis of response to treatment,1.0), (Improved detection,would facilitate,diagnosis of response,1.0), (detection,would facilitate,diagnosis,1.0), (Improved detection,would facilitate,diagnosis of response to treatment,1.0), (Improved detection,would facilitate,surveillance,1.0), (detection,would facilitate,surveillance,1.0), (detection,would facilitate,diagnosis of response,1.0)][(Improved detection,would facilitate,assessment,1.0), (Improved detection,would facilitate,diagnosis,1.0), (detection,would facilitate,assessment,1.0), (detection,would facilitate,diagnosis of response to treatment,1.0), (Improved detection,would facilitate,diagnosis of response,1.0), (detection,would facilitate,diagnosis,1.0), (Improved detection,would facilitate,diagnosis of response to treatment,1.0), (Improved detection,would facilitate,surveillance,1.0), (detection,would facilitate,surveillance,1.0), (detection,would facilitate,diagnosis of response,1.0)][(Improved detection,would facilitate,assessment,1.0), (Improved detection,would facilitate,diagnosis,1.0), (detection,would facilitate,assessment,1.0), (detection,would facilitate,diagnosis of response to treatment,1.0), (Improved detection,would facilitate,diagnosis of response,1.0), (detection,would facilitate,diagnosis,1.0), (Improved detection,would facilitate,diagnosis of response to treatment,1.0), (Improved detection,would facilitate,surveillance,1.0), (detection,would facilitate,surveillance,1.0), (detection,would facilitate,diagnosis of response,1.0)][(Improved detection,would facilitate,assessment,1.0), (Improved detection,would facilitate,diagnosis,1.0), (detection,would facilitate,assessment,1.0), (detection,would facilitate,diagnosis of response to treatment,1.0), (Improved detection,would facilitate,diagnosis of response,1.0), (detection,would facilitate,diagnosis,1.0), (Improved detection,would facilitate,diagnosis of response to treatment,1.0), (Improved detection,would facilitate,surveillance,1.0), (detection,would facilitate,surveillance,1.0), (detection,would facilitate,diagnosis of response,1.0)][(Improved detection,would facilitate,assessment,1.0), (Improved detection,would facilitate,diagnosis,1.0), (detection,would facilitate,assessment,1.0), (detection,would facilitate,diagnosis of response to treatment,1.0), (Improved detection,would facilitate,diagnosis of response,1.0), (detection,would facilitate,diagnosis,1.0), (Improved detection,would facilitate,diagnosis of response to treatment,1.0), (Improved detection,would facilitate,surveillance,1.0), (detection,would facilitate,surveillance,1.0), (detection,would facilitate,diagnosis of response,1.0)][(Improved detection,would facilitate,assessment,1.0), (Improved detection,would facilitate,diagnosis,1.0), (detection,would facilitate,assessment,1.0), (detection,would facilitate,diagnosis of response to treatment,1.0), (Improved detection,would facilitate,diagnosis of response,1.0), (detection,would facilitate,diagnosis,1.0), (Improved detection,would facilitate,diagnosis of response to treatment,1.0), (Improved detection,would facilitate,surveillance,1.0), (detection,would facilitate,surveillance,1.0), (detection,would facilitate,diagnosis of response,1.0)][(Improved detection,would facilitate,assessment,1.0), (Improved detection,would facilitate,diagnosis,1.0), (detection,would facilitate,assessment,1.0), (detection,would facilitate,diagnosis of response to treatment,1.0), (Improved detection,would facilitate,diagnosis of response,1.0), (detection,would facilitate,diagnosis,1.0), (Improved detection,would facilitate,diagnosis of response to treatment,1.0), (Improved detection,would facilitate,surveillance,1.0), (detection,would facilitate,surveillance,1.0), (detection,would facilitate,diagnosis of response,1.0)][(Improved detection,would facilitate,assessment,1.0), (Improved detection,would facilitate,diagnosis,1.0), (detection,would facilitate,assessment,1.0), (detection,would facilitate,diagnosis of response to treatment,1.0), (Improved detection,would facilitate,diagnosis of response,1.0), (detection,would facilitate,diagnosis,1.0), (Improved detection,would facilitate,diagnosis of response to treatment,1.0), (Improved detection,would facilitate,surveillance,1.0), (detection,would facilitate,surveillance,1.0), (detection,would facilitate,diagnosis of response,1.0)][(Improved detection,would facilitate,assessment,1.0), (Improved detection,would facilitate,diagnosis,1.0), (detection,would facilitate,assessment,1.0), (detection,would facilitate,diagnosis of response to treatment,1.0), (Improved detection,would facilitate,diagnosis of response,1.0), (detection,would facilitate,diagnosis,1.0), (Improved detection,would facilitate,diagnosis of response to treatment,1.0), (Improved detection,would facilitate,surveillance,1.0), (detection,would facilitate,surveillance,1.0), (detection,would facilitate,diagnosis of response,1.0)][(We,conjugated osteopontin peptide to,infrared fluorescent,1.0), (We,conjugated,osteopontin peptide,1.0), (We,conjugated osteopontin peptide to,fluorescent,1.0), (We,conjugated osteopontin peptide to,fluorescent dye,1.0), (We,conjugated osteopontin peptide to,infrared fluorescent dye,1.0)][(We,conjugated osteopontin peptide to,infrared fluorescent,1.0), (We,conjugated,osteopontin peptide,1.0), (We,conjugated osteopontin peptide to,fluorescent,1.0), (We,conjugated osteopontin peptide to,fluorescent dye,1.0), (We,conjugated osteopontin peptide to,infrared fluorescent dye,1.0)][(We,conjugated osteopontin peptide to,infrared fluorescent,1.0), (We,conjugated,osteopontin peptide,1.0), (We,conjugated osteopontin peptide to,fluorescent,1.0), (We,conjugated osteopontin peptide to,fluorescent dye,1.0), (We,conjugated osteopontin peptide to,infrared fluorescent dye,1.0)][(We,conjugated osteopontin peptide to,infrared fluorescent,1.0), (We,conjugated,osteopontin peptide,1.0), (We,conjugated osteopontin peptide to,fluorescent,1.0), (We,conjugated osteopontin peptide to,fluorescent dye,1.0), (We,conjugated osteopontin peptide to,infrared fluorescent dye,1.0)][(We,conjugated osteopontin peptide to,infrared fluorescent,1.0), (We,conjugated,osteopontin peptide,1.0), (We,conjugated osteopontin peptide to,fluorescent,1.0), (We,conjugated osteopontin peptide to,fluorescent dye,1.0), (We,conjugated osteopontin peptide to,infrared fluorescent dye,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(binding,using,fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging,1.0), (Selective binding,was,identified,1.0), (binding,using,imaging,1.0), (binding,using,fluorescent imaging in triple negative,1.0), (Selective binding,using,imaging in negative,1.0), (binding,using,fluorescent imaging,1.0), (binding,using,infrared fluorescent imaging,1.0), (Selective binding,using,infrared fluorescent imaging,1.0), (binding,using,imaging in negative,1.0), (binding,using,infrared imaging in negative,1.0), (binding,using,fluorescent imaging in negative,1.0), (Selective binding,using,infrared imaging in negative,1.0), (binding,was,identified,1.0), (binding,using,infrared imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in triple negative,1.0), (binding,using,infrared fluorescent imaging in negative in vitro,1.0), (binding,using,infrared imaging in negative in vitro,1.0), (Selective binding,using,fluorescent imaging in negative,1.0), (binding,using,flow cytometry,1.0), (Selective binding,using,fluorescent imaging,1.0), (binding,using,imaging in negative in vitro,1.0), (binding,using,infrared imaging in triple negative in vitro,1.0), (binding,using,imaging in triple negative,1.0), (binding,using,fluorescent imaging in triple negative in vitro,1.0), (Selective binding,using,infrared fluorescent imaging in negative,1.0), (Selective binding,using,flow cytometry,1.0), (Selective binding,using,imaging,1.0), (binding,using,infrared fluorescent imaging in negative,1.0), (binding,using,imaging in triple negative in vitro,1.0), (Selective binding,using,infrared imaging,1.0), (binding,using,infrared fluorescent imaging in triple negative in vitro,1.0), (infrared fluorescent imaging,is in,triple negative in vitro,1.0)][(Osteopontin-750 accumulation,using MSOT with,confirmation,1.0), (Osteopontin-750 accumulation,was,evaluated in vivo,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation,1.0), (Osteopontin-750 accumulation,using,MSOT,1.0), (Osteopontin-750 accumulation,was,evaluated,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near imaging,1.0)][(Osteopontin-750 accumulation,using MSOT with,confirmation,1.0), (Osteopontin-750 accumulation,was,evaluated in vivo,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation,1.0), (Osteopontin-750 accumulation,using,MSOT,1.0), (Osteopontin-750 accumulation,was,evaluated,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near imaging,1.0)][(Osteopontin-750 accumulation,using MSOT with,confirmation,1.0), (Osteopontin-750 accumulation,was,evaluated in vivo,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation,1.0), (Osteopontin-750 accumulation,using,MSOT,1.0), (Osteopontin-750 accumulation,was,evaluated,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near imaging,1.0)][(Osteopontin-750 accumulation,using MSOT with,confirmation,1.0), (Osteopontin-750 accumulation,was,evaluated in vivo,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation,1.0), (Osteopontin-750 accumulation,using,MSOT,1.0), (Osteopontin-750 accumulation,was,evaluated,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near imaging,1.0)][(Osteopontin-750 accumulation,using MSOT with,confirmation,1.0), (Osteopontin-750 accumulation,was,evaluated in vivo,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation,1.0), (Osteopontin-750 accumulation,using,MSOT,1.0), (Osteopontin-750 accumulation,was,evaluated,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near imaging,1.0)][(Osteopontin-750 accumulation,using MSOT with,confirmation,1.0), (Osteopontin-750 accumulation,was,evaluated in vivo,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation,1.0), (Osteopontin-750 accumulation,using,MSOT,1.0), (Osteopontin-750 accumulation,was,evaluated,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near imaging,1.0)][(Osteopontin-750 accumulation,using MSOT with,confirmation,1.0), (Osteopontin-750 accumulation,was,evaluated in vivo,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation,1.0), (Osteopontin-750 accumulation,using,MSOT,1.0), (Osteopontin-750 accumulation,was,evaluated,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near imaging,1.0)][(Osteopontin-750 accumulation,using MSOT with,confirmation,1.0), (Osteopontin-750 accumulation,was,evaluated in vivo,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation,1.0), (Osteopontin-750 accumulation,using,MSOT,1.0), (Osteopontin-750 accumulation,was,evaluated,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near imaging,1.0)][(Osteopontin-750 accumulation,using MSOT with,confirmation,1.0), (Osteopontin-750 accumulation,was,evaluated in vivo,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation,1.0), (Osteopontin-750 accumulation,using,MSOT,1.0), (Osteopontin-750 accumulation,was,evaluated,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near imaging,1.0)][(Osteopontin-750 accumulation,using MSOT with,confirmation,1.0), (Osteopontin-750 accumulation,was,evaluated in vivo,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation,1.0), (Osteopontin-750 accumulation,using,MSOT,1.0), (Osteopontin-750 accumulation,was,evaluated,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near imaging,1.0)][(Osteopontin-750 accumulation,using MSOT with,confirmation,1.0), (Osteopontin-750 accumulation,was,evaluated in vivo,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation,1.0), (Osteopontin-750 accumulation,using,MSOT,1.0), (Osteopontin-750 accumulation,was,evaluated,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near imaging,1.0)][(Osteopontin-750 accumulation,using MSOT with,confirmation,1.0), (Osteopontin-750 accumulation,was,evaluated in vivo,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation,1.0), (Osteopontin-750 accumulation,using,MSOT,1.0), (Osteopontin-750 accumulation,was,evaluated,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near imaging,1.0)][(Osteopontin-750 accumulation,using MSOT with,confirmation,1.0), (Osteopontin-750 accumulation,was,evaluated in vivo,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation,1.0), (Osteopontin-750 accumulation,using,MSOT,1.0), (Osteopontin-750 accumulation,was,evaluated,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near imaging,1.0)][(Osteopontin-750 accumulation,using MSOT with,confirmation,1.0), (Osteopontin-750 accumulation,was,evaluated in vivo,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation,1.0), (Osteopontin-750 accumulation,using,MSOT,1.0), (Osteopontin-750 accumulation,was,evaluated,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near imaging,1.0)][(Osteopontin-750 accumulation,using MSOT with,confirmation,1.0), (Osteopontin-750 accumulation,was,evaluated in vivo,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation,1.0), (Osteopontin-750 accumulation,using,MSOT,1.0), (Osteopontin-750 accumulation,was,evaluated,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near imaging,1.0)][(Osteopontin-750 accumulation,using MSOT with,confirmation,1.0), (Osteopontin-750 accumulation,was,evaluated in vivo,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation,1.0), (Osteopontin-750 accumulation,using,MSOT,1.0), (Osteopontin-750 accumulation,was,evaluated,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near imaging,1.0)][(Osteopontin-750 accumulation,using MSOT with,confirmation,1.0), (Osteopontin-750 accumulation,was,evaluated in vivo,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation,1.0), (Osteopontin-750 accumulation,using,MSOT,1.0), (Osteopontin-750 accumulation,was,evaluated,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near imaging,1.0)][(Osteopontin-750 accumulation,using MSOT with,confirmation,1.0), (Osteopontin-750 accumulation,was,evaluated in vivo,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation,1.0), (Osteopontin-750 accumulation,using,MSOT,1.0), (Osteopontin-750 accumulation,was,evaluated,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near imaging,1.0)][(Osteopontin-750 accumulation,using MSOT with,confirmation,1.0), (Osteopontin-750 accumulation,was,evaluated in vivo,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation,1.0), (Osteopontin-750 accumulation,using,MSOT,1.0), (Osteopontin-750 accumulation,was,evaluated,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near imaging,1.0)][(Osteopontin-750 accumulation,using MSOT with,confirmation,1.0), (Osteopontin-750 accumulation,was,evaluated in vivo,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation,1.0), (Osteopontin-750 accumulation,using,MSOT,1.0), (Osteopontin-750 accumulation,was,evaluated,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near imaging,1.0)][(Osteopontin-750 accumulation,using MSOT with,confirmation,1.0), (Osteopontin-750 accumulation,was,evaluated in vivo,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation,1.0), (Osteopontin-750 accumulation,using,MSOT,1.0), (Osteopontin-750 accumulation,was,evaluated,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near imaging,1.0)][(Osteopontin-750 accumulation,using MSOT with,confirmation,1.0), (Osteopontin-750 accumulation,was,evaluated in vivo,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation,1.0), (Osteopontin-750 accumulation,using,MSOT,1.0), (Osteopontin-750 accumulation,was,evaluated,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near imaging,1.0)][(Osteopontin-750 accumulation,using MSOT with,confirmation,1.0), (Osteopontin-750 accumulation,was,evaluated in vivo,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation,1.0), (Osteopontin-750 accumulation,using,MSOT,1.0), (Osteopontin-750 accumulation,was,evaluated,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near imaging,1.0)][(Osteopontin-750 accumulation,using MSOT with,confirmation,1.0), (Osteopontin-750 accumulation,was,evaluated in vivo,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation,1.0), (Osteopontin-750 accumulation,using,MSOT,1.0), (Osteopontin-750 accumulation,was,evaluated,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near imaging,1.0)][(Osteopontin-750 accumulation,using MSOT with,confirmation,1.0), (Osteopontin-750 accumulation,was,evaluated in vivo,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation,1.0), (Osteopontin-750 accumulation,using,MSOT,1.0), (Osteopontin-750 accumulation,was,evaluated,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near imaging,1.0)][(Osteopontin-750 accumulation,using MSOT with,confirmation,1.0), (Osteopontin-750 accumulation,was,evaluated in vivo,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation,1.0), (Osteopontin-750 accumulation,using,MSOT,1.0), (Osteopontin-750 accumulation,was,evaluated,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near imaging,1.0)][(Osteopontin-750 accumulation,using MSOT with,confirmation,1.0), (Osteopontin-750 accumulation,was,evaluated in vivo,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation,1.0), (Osteopontin-750 accumulation,using,MSOT,1.0), (Osteopontin-750 accumulation,was,evaluated,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near fluorescent imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation of signal accumulation using,1.0), (Osteopontin-750 accumulation,using MSOT with,confirmation using,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation of signal accumulation using near infrared imaging,1.0), (Osteopontin-750 accumulation,using MSOT with,secondary confirmation using near imaging,1.0)][(osteopontin-based probe,demonstrated,binding,1.0), (probe,demonstrated,binding to breast cancer cells in vitro,1.0), (osteopontin-based probe,demonstrated,binding to breast cancer cells in vitro,1.0), (osteopontin-based probe,demonstrated,binding in vitro,1.0), (probe,demonstrated,binding to breast cancer cells,1.0), (osteopontin-based probe,demonstrated,binding to breast cancer cells,1.0), (probe,demonstrated,binding in vitro,1.0), (probe,demonstrated,binding,1.0)][(osteopontin-based probe,demonstrated,binding,1.0), (probe,demonstrated,binding to breast cancer cells in vitro,1.0), (osteopontin-based probe,demonstrated,binding to breast cancer cells in vitro,1.0), (osteopontin-based probe,demonstrated,binding in vitro,1.0), (probe,demonstrated,binding to breast cancer cells,1.0), (osteopontin-based probe,demonstrated,binding to breast cancer cells,1.0), (probe,demonstrated,binding in vitro,1.0), (probe,demonstrated,binding,1.0)][(osteopontin-based probe,demonstrated,binding,1.0), (probe,demonstrated,binding to breast cancer cells in vitro,1.0), (osteopontin-based probe,demonstrated,binding to breast cancer cells in vitro,1.0), (osteopontin-based probe,demonstrated,binding in vitro,1.0), (probe,demonstrated,binding to breast cancer cells,1.0), (osteopontin-based probe,demonstrated,binding to breast cancer cells,1.0), (probe,demonstrated,binding in vitro,1.0), (probe,demonstrated,binding,1.0)][(osteopontin-based probe,demonstrated,binding,1.0), (probe,demonstrated,binding to breast cancer cells in vitro,1.0), (osteopontin-based probe,demonstrated,binding to breast cancer cells in vitro,1.0), (osteopontin-based probe,demonstrated,binding in vitro,1.0), (probe,demonstrated,binding to breast cancer cells,1.0), (osteopontin-based probe,demonstrated,binding to breast cancer cells,1.0), (probe,demonstrated,binding in vitro,1.0), (probe,demonstrated,binding,1.0)][(osteopontin-based probe,demonstrated,binding,1.0), (probe,demonstrated,binding to breast cancer cells in vitro,1.0), (osteopontin-based probe,demonstrated,binding to breast cancer cells in vitro,1.0), (osteopontin-based probe,demonstrated,binding in vitro,1.0), (probe,demonstrated,binding to breast cancer cells,1.0), (osteopontin-based probe,demonstrated,binding to breast cancer cells,1.0), (probe,demonstrated,binding in vitro,1.0), (probe,demonstrated,binding,1.0)][(osteopontin-based probe,demonstrated,binding,1.0), (probe,demonstrated,binding to breast cancer cells in vitro,1.0), (osteopontin-based probe,demonstrated,binding to breast cancer cells in vitro,1.0), (osteopontin-based probe,demonstrated,binding in vitro,1.0), (probe,demonstrated,binding to breast cancer cells,1.0), (osteopontin-based probe,demonstrated,binding to breast cancer cells,1.0), (probe,demonstrated,binding in vitro,1.0), (probe,demonstrated,binding,1.0)][(osteopontin-based probe,demonstrated,binding,1.0), (probe,demonstrated,binding to breast cancer cells in vitro,1.0), (osteopontin-based probe,demonstrated,binding to breast cancer cells in vitro,1.0), (osteopontin-based probe,demonstrated,binding in vitro,1.0), (probe,demonstrated,binding to breast cancer cells,1.0), (osteopontin-based probe,demonstrated,binding to breast cancer cells,1.0), (probe,demonstrated,binding in vitro,1.0), (probe,demonstrated,binding,1.0)][(osteopontin-based probe,demonstrated,binding,1.0), (probe,demonstrated,binding to breast cancer cells in vitro,1.0), (osteopontin-based probe,demonstrated,binding to breast cancer cells in vitro,1.0), (osteopontin-based probe,demonstrated,binding in vitro,1.0), (probe,demonstrated,binding to breast cancer cells,1.0), (osteopontin-based probe,demonstrated,binding to breast cancer cells,1.0), (probe,demonstrated,binding in vitro,1.0), (probe,demonstrated,binding,1.0)][(subcutaneous breast tumor,is in,nude mice,1.0), (it,accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated after,administration,1.0), (it,accumulated in,breast tumor,1.0), (it,Similarly accumulated after,administration,1.0), (it,accumulated after,intravenous administration,1.0), (it,Similarly accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,Similarly accumulated after,intravenous administration,1.0), (it,Similarly accumulated in,breast tumor,1.0), (it,accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in nude mice,1.0), (it,accumulated in,subcutaneous breast tumor,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in mice,1.0), (it,accumulated in,breast tumor in nude mice,1.0), (it,Similarly accumulated in,subcutaneous breast tumor,1.0)][(subcutaneous breast tumor,is in,nude mice,1.0), (it,accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated after,administration,1.0), (it,accumulated in,breast tumor,1.0), (it,Similarly accumulated after,administration,1.0), (it,accumulated after,intravenous administration,1.0), (it,Similarly accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,Similarly accumulated after,intravenous administration,1.0), (it,Similarly accumulated in,breast tumor,1.0), (it,accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in nude mice,1.0), (it,accumulated in,subcutaneous breast tumor,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in mice,1.0), (it,accumulated in,breast tumor in nude mice,1.0), (it,Similarly accumulated in,subcutaneous breast tumor,1.0)][(subcutaneous breast tumor,is in,nude mice,1.0), (it,accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated after,administration,1.0), (it,accumulated in,breast tumor,1.0), (it,Similarly accumulated after,administration,1.0), (it,accumulated after,intravenous administration,1.0), (it,Similarly accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,Similarly accumulated after,intravenous administration,1.0), (it,Similarly accumulated in,breast tumor,1.0), (it,accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in nude mice,1.0), (it,accumulated in,subcutaneous breast tumor,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in mice,1.0), (it,accumulated in,breast tumor in nude mice,1.0), (it,Similarly accumulated in,subcutaneous breast tumor,1.0)][(subcutaneous breast tumor,is in,nude mice,1.0), (it,accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated after,administration,1.0), (it,accumulated in,breast tumor,1.0), (it,Similarly accumulated after,administration,1.0), (it,accumulated after,intravenous administration,1.0), (it,Similarly accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,Similarly accumulated after,intravenous administration,1.0), (it,Similarly accumulated in,breast tumor,1.0), (it,accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in nude mice,1.0), (it,accumulated in,subcutaneous breast tumor,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in mice,1.0), (it,accumulated in,breast tumor in nude mice,1.0), (it,Similarly accumulated in,subcutaneous breast tumor,1.0)][(subcutaneous breast tumor,is in,nude mice,1.0), (it,accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated after,administration,1.0), (it,accumulated in,breast tumor,1.0), (it,Similarly accumulated after,administration,1.0), (it,accumulated after,intravenous administration,1.0), (it,Similarly accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,Similarly accumulated after,intravenous administration,1.0), (it,Similarly accumulated in,breast tumor,1.0), (it,accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in nude mice,1.0), (it,accumulated in,subcutaneous breast tumor,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in mice,1.0), (it,accumulated in,breast tumor in nude mice,1.0), (it,Similarly accumulated in,subcutaneous breast tumor,1.0)][(subcutaneous breast tumor,is in,nude mice,1.0), (it,accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated after,administration,1.0), (it,accumulated in,breast tumor,1.0), (it,Similarly accumulated after,administration,1.0), (it,accumulated after,intravenous administration,1.0), (it,Similarly accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,Similarly accumulated after,intravenous administration,1.0), (it,Similarly accumulated in,breast tumor,1.0), (it,accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in nude mice,1.0), (it,accumulated in,subcutaneous breast tumor,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in mice,1.0), (it,accumulated in,breast tumor in nude mice,1.0), (it,Similarly accumulated in,subcutaneous breast tumor,1.0)][(subcutaneous breast tumor,is in,nude mice,1.0), (it,accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated after,administration,1.0), (it,accumulated in,breast tumor,1.0), (it,Similarly accumulated after,administration,1.0), (it,accumulated after,intravenous administration,1.0), (it,Similarly accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,Similarly accumulated after,intravenous administration,1.0), (it,Similarly accumulated in,breast tumor,1.0), (it,accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in nude mice,1.0), (it,accumulated in,subcutaneous breast tumor,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in mice,1.0), (it,accumulated in,breast tumor in nude mice,1.0), (it,Similarly accumulated in,subcutaneous breast tumor,1.0)][(subcutaneous breast tumor,is in,nude mice,1.0), (it,accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated after,administration,1.0), (it,accumulated in,breast tumor,1.0), (it,Similarly accumulated after,administration,1.0), (it,accumulated after,intravenous administration,1.0), (it,Similarly accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,Similarly accumulated after,intravenous administration,1.0), (it,Similarly accumulated in,breast tumor,1.0), (it,accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in nude mice,1.0), (it,accumulated in,subcutaneous breast tumor,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in mice,1.0), (it,accumulated in,breast tumor in nude mice,1.0), (it,Similarly accumulated in,subcutaneous breast tumor,1.0)][(subcutaneous breast tumor,is in,nude mice,1.0), (it,accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated after,administration,1.0), (it,accumulated in,breast tumor,1.0), (it,Similarly accumulated after,administration,1.0), (it,accumulated after,intravenous administration,1.0), (it,Similarly accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,Similarly accumulated after,intravenous administration,1.0), (it,Similarly accumulated in,breast tumor,1.0), (it,accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in nude mice,1.0), (it,accumulated in,subcutaneous breast tumor,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in mice,1.0), (it,accumulated in,breast tumor in nude mice,1.0), (it,Similarly accumulated in,subcutaneous breast tumor,1.0)][(subcutaneous breast tumor,is in,nude mice,1.0), (it,accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated after,administration,1.0), (it,accumulated in,breast tumor,1.0), (it,Similarly accumulated after,administration,1.0), (it,accumulated after,intravenous administration,1.0), (it,Similarly accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,Similarly accumulated after,intravenous administration,1.0), (it,Similarly accumulated in,breast tumor,1.0), (it,accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in nude mice,1.0), (it,accumulated in,subcutaneous breast tumor,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in mice,1.0), (it,accumulated in,breast tumor in nude mice,1.0), (it,Similarly accumulated in,subcutaneous breast tumor,1.0)][(subcutaneous breast tumor,is in,nude mice,1.0), (it,accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated after,administration,1.0), (it,accumulated in,breast tumor,1.0), (it,Similarly accumulated after,administration,1.0), (it,accumulated after,intravenous administration,1.0), (it,Similarly accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,Similarly accumulated after,intravenous administration,1.0), (it,Similarly accumulated in,breast tumor,1.0), (it,accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in nude mice,1.0), (it,accumulated in,subcutaneous breast tumor,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in mice,1.0), (it,accumulated in,breast tumor in nude mice,1.0), (it,Similarly accumulated in,subcutaneous breast tumor,1.0)][(subcutaneous breast tumor,is in,nude mice,1.0), (it,accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated after,administration,1.0), (it,accumulated in,breast tumor,1.0), (it,Similarly accumulated after,administration,1.0), (it,accumulated after,intravenous administration,1.0), (it,Similarly accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,Similarly accumulated after,intravenous administration,1.0), (it,Similarly accumulated in,breast tumor,1.0), (it,accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in nude mice,1.0), (it,accumulated in,subcutaneous breast tumor,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in mice,1.0), (it,accumulated in,breast tumor in nude mice,1.0), (it,Similarly accumulated in,subcutaneous breast tumor,1.0)][(subcutaneous breast tumor,is in,nude mice,1.0), (it,accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated after,administration,1.0), (it,accumulated in,breast tumor,1.0), (it,Similarly accumulated after,administration,1.0), (it,accumulated after,intravenous administration,1.0), (it,Similarly accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,Similarly accumulated after,intravenous administration,1.0), (it,Similarly accumulated in,breast tumor,1.0), (it,accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in nude mice,1.0), (it,accumulated in,subcutaneous breast tumor,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in mice,1.0), (it,accumulated in,breast tumor in nude mice,1.0), (it,Similarly accumulated in,subcutaneous breast tumor,1.0)][(subcutaneous breast tumor,is in,nude mice,1.0), (it,accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated after,administration,1.0), (it,accumulated in,breast tumor,1.0), (it,Similarly accumulated after,administration,1.0), (it,accumulated after,intravenous administration,1.0), (it,Similarly accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,Similarly accumulated after,intravenous administration,1.0), (it,Similarly accumulated in,breast tumor,1.0), (it,accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in nude mice,1.0), (it,accumulated in,subcutaneous breast tumor,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in mice,1.0), (it,accumulated in,breast tumor in nude mice,1.0), (it,Similarly accumulated in,subcutaneous breast tumor,1.0)][(subcutaneous breast tumor,is in,nude mice,1.0), (it,accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated after,administration,1.0), (it,accumulated in,breast tumor,1.0), (it,Similarly accumulated after,administration,1.0), (it,accumulated after,intravenous administration,1.0), (it,Similarly accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,Similarly accumulated after,intravenous administration,1.0), (it,Similarly accumulated in,breast tumor,1.0), (it,accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in nude mice,1.0), (it,accumulated in,subcutaneous breast tumor,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in mice,1.0), (it,accumulated in,breast tumor in nude mice,1.0), (it,Similarly accumulated in,subcutaneous breast tumor,1.0)][(subcutaneous breast tumor,is in,nude mice,1.0), (it,accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated after,administration,1.0), (it,accumulated in,breast tumor,1.0), (it,Similarly accumulated after,administration,1.0), (it,accumulated after,intravenous administration,1.0), (it,Similarly accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,Similarly accumulated after,intravenous administration,1.0), (it,Similarly accumulated in,breast tumor,1.0), (it,accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in nude mice,1.0), (it,accumulated in,subcutaneous breast tumor,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in mice,1.0), (it,accumulated in,breast tumor in nude mice,1.0), (it,Similarly accumulated in,subcutaneous breast tumor,1.0)][(subcutaneous breast tumor,is in,nude mice,1.0), (it,accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated after,administration,1.0), (it,accumulated in,breast tumor,1.0), (it,Similarly accumulated after,administration,1.0), (it,accumulated after,intravenous administration,1.0), (it,Similarly accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,Similarly accumulated after,intravenous administration,1.0), (it,Similarly accumulated in,breast tumor,1.0), (it,accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in nude mice,1.0), (it,accumulated in,subcutaneous breast tumor,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in mice,1.0), (it,accumulated in,breast tumor in nude mice,1.0), (it,Similarly accumulated in,subcutaneous breast tumor,1.0)][(subcutaneous breast tumor,is in,nude mice,1.0), (it,accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated after,administration,1.0), (it,accumulated in,breast tumor,1.0), (it,Similarly accumulated after,administration,1.0), (it,accumulated after,intravenous administration,1.0), (it,Similarly accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,Similarly accumulated after,intravenous administration,1.0), (it,Similarly accumulated in,breast tumor,1.0), (it,accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in nude mice,1.0), (it,accumulated in,subcutaneous breast tumor,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in mice,1.0), (it,accumulated in,breast tumor in nude mice,1.0), (it,Similarly accumulated in,subcutaneous breast tumor,1.0)][(subcutaneous breast tumor,is in,nude mice,1.0), (it,accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated after,administration,1.0), (it,accumulated in,breast tumor,1.0), (it,Similarly accumulated after,administration,1.0), (it,accumulated after,intravenous administration,1.0), (it,Similarly accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,Similarly accumulated after,intravenous administration,1.0), (it,Similarly accumulated in,breast tumor,1.0), (it,accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in nude mice,1.0), (it,accumulated in,subcutaneous breast tumor,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in mice,1.0), (it,accumulated in,breast tumor in nude mice,1.0), (it,Similarly accumulated in,subcutaneous breast tumor,1.0)][(subcutaneous breast tumor,is in,nude mice,1.0), (it,accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated after,administration,1.0), (it,accumulated in,breast tumor,1.0), (it,Similarly accumulated after,administration,1.0), (it,accumulated after,intravenous administration,1.0), (it,Similarly accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,Similarly accumulated after,intravenous administration,1.0), (it,Similarly accumulated in,breast tumor,1.0), (it,accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in nude mice,1.0), (it,accumulated in,subcutaneous breast tumor,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in mice,1.0), (it,accumulated in,breast tumor in nude mice,1.0), (it,Similarly accumulated in,subcutaneous breast tumor,1.0)][(subcutaneous breast tumor,is in,nude mice,1.0), (it,accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated after,administration,1.0), (it,accumulated in,breast tumor,1.0), (it,Similarly accumulated after,administration,1.0), (it,accumulated after,intravenous administration,1.0), (it,Similarly accumulated after,administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,Similarly accumulated after,intravenous administration,1.0), (it,Similarly accumulated in,breast tumor,1.0), (it,accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,accumulated in,subcutaneous breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated in,breast tumor in nude mice,1.0), (it,accumulated in,subcutaneous breast tumor,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in nude mice,1.0), (it,accumulated in,breast tumor in mice,1.0), (it,Similarly accumulated after,intravenous administration of osteopontin-750 probe,1.0), (it,Similarly accumulated in,subcutaneous breast tumor in mice,1.0), (it,accumulated in,breast tumor in nude mice,1.0), (it,Similarly accumulated in,subcutaneous breast tumor,1.0)][(signal intensity,was,greater in tumor bed than in kidney respectively,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed than in kidney respectively,1.0), (signal intensity,was,At 2.5 h post-injection greater than in kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed respectively,1.0), (signal intensity,was,greater in tumor bed than in kidney,1.0), (signal intensity,was,greater respectively,1.0), (signal intensity,was greater in,tumor bed,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed,1.0), (signal intensity,was greater respectively At,2.5 h post-injection,1.0), (signal intensity,was greater respectively than,than kidney,1.0), (signal intensity,was greater than,than kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed than in kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater than in kidney respectively,1.0), (signal intensity,was greater respectively in,tumor bed,1.0), (signal intensity,was greater At,2.5 h post-injection,1.0), (signal intensity,was,greater,1.0)][(signal intensity,was,greater in tumor bed than in kidney respectively,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed than in kidney respectively,1.0), (signal intensity,was,At 2.5 h post-injection greater than in kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed respectively,1.0), (signal intensity,was,greater in tumor bed than in kidney,1.0), (signal intensity,was,greater respectively,1.0), (signal intensity,was greater in,tumor bed,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed,1.0), (signal intensity,was greater respectively At,2.5 h post-injection,1.0), (signal intensity,was greater respectively than,than kidney,1.0), (signal intensity,was greater than,than kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed than in kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater than in kidney respectively,1.0), (signal intensity,was greater respectively in,tumor bed,1.0), (signal intensity,was greater At,2.5 h post-injection,1.0), (signal intensity,was,greater,1.0)][(signal intensity,was,greater in tumor bed than in kidney respectively,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed than in kidney respectively,1.0), (signal intensity,was,At 2.5 h post-injection greater than in kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed respectively,1.0), (signal intensity,was,greater in tumor bed than in kidney,1.0), (signal intensity,was,greater respectively,1.0), (signal intensity,was greater in,tumor bed,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed,1.0), (signal intensity,was greater respectively At,2.5 h post-injection,1.0), (signal intensity,was greater respectively than,than kidney,1.0), (signal intensity,was greater than,than kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed than in kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater than in kidney respectively,1.0), (signal intensity,was greater respectively in,tumor bed,1.0), (signal intensity,was greater At,2.5 h post-injection,1.0), (signal intensity,was,greater,1.0)][(signal intensity,was,greater in tumor bed than in kidney respectively,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed than in kidney respectively,1.0), (signal intensity,was,At 2.5 h post-injection greater than in kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed respectively,1.0), (signal intensity,was,greater in tumor bed than in kidney,1.0), (signal intensity,was,greater respectively,1.0), (signal intensity,was greater in,tumor bed,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed,1.0), (signal intensity,was greater respectively At,2.5 h post-injection,1.0), (signal intensity,was greater respectively than,than kidney,1.0), (signal intensity,was greater than,than kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed than in kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater than in kidney respectively,1.0), (signal intensity,was greater respectively in,tumor bed,1.0), (signal intensity,was greater At,2.5 h post-injection,1.0), (signal intensity,was,greater,1.0)][(signal intensity,was,greater in tumor bed than in kidney respectively,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed than in kidney respectively,1.0), (signal intensity,was,At 2.5 h post-injection greater than in kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed respectively,1.0), (signal intensity,was,greater in tumor bed than in kidney,1.0), (signal intensity,was,greater respectively,1.0), (signal intensity,was greater in,tumor bed,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed,1.0), (signal intensity,was greater respectively At,2.5 h post-injection,1.0), (signal intensity,was greater respectively than,than kidney,1.0), (signal intensity,was greater than,than kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed than in kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater than in kidney respectively,1.0), (signal intensity,was greater respectively in,tumor bed,1.0), (signal intensity,was greater At,2.5 h post-injection,1.0), (signal intensity,was,greater,1.0)][(signal intensity,was,greater in tumor bed than in kidney respectively,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed than in kidney respectively,1.0), (signal intensity,was,At 2.5 h post-injection greater than in kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed respectively,1.0), (signal intensity,was,greater in tumor bed than in kidney,1.0), (signal intensity,was,greater respectively,1.0), (signal intensity,was greater in,tumor bed,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed,1.0), (signal intensity,was greater respectively At,2.5 h post-injection,1.0), (signal intensity,was greater respectively than,than kidney,1.0), (signal intensity,was greater than,than kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed than in kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater than in kidney respectively,1.0), (signal intensity,was greater respectively in,tumor bed,1.0), (signal intensity,was greater At,2.5 h post-injection,1.0), (signal intensity,was,greater,1.0)][(signal intensity,was,greater in tumor bed than in kidney respectively,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed than in kidney respectively,1.0), (signal intensity,was,At 2.5 h post-injection greater than in kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed respectively,1.0), (signal intensity,was,greater in tumor bed than in kidney,1.0), (signal intensity,was,greater respectively,1.0), (signal intensity,was greater in,tumor bed,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed,1.0), (signal intensity,was greater respectively At,2.5 h post-injection,1.0), (signal intensity,was greater respectively than,than kidney,1.0), (signal intensity,was greater than,than kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed than in kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater than in kidney respectively,1.0), (signal intensity,was greater respectively in,tumor bed,1.0), (signal intensity,was greater At,2.5 h post-injection,1.0), (signal intensity,was,greater,1.0)][(signal intensity,was,greater in tumor bed than in kidney respectively,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed than in kidney respectively,1.0), (signal intensity,was,At 2.5 h post-injection greater than in kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed respectively,1.0), (signal intensity,was,greater in tumor bed than in kidney,1.0), (signal intensity,was,greater respectively,1.0), (signal intensity,was greater in,tumor bed,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed,1.0), (signal intensity,was greater respectively At,2.5 h post-injection,1.0), (signal intensity,was greater respectively than,than kidney,1.0), (signal intensity,was greater than,than kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed than in kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater than in kidney respectively,1.0), (signal intensity,was greater respectively in,tumor bed,1.0), (signal intensity,was greater At,2.5 h post-injection,1.0), (signal intensity,was,greater,1.0)][(signal intensity,was,greater in tumor bed than in kidney respectively,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed than in kidney respectively,1.0), (signal intensity,was,At 2.5 h post-injection greater than in kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed respectively,1.0), (signal intensity,was,greater in tumor bed than in kidney,1.0), (signal intensity,was,greater respectively,1.0), (signal intensity,was greater in,tumor bed,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed,1.0), (signal intensity,was greater respectively At,2.5 h post-injection,1.0), (signal intensity,was greater respectively than,than kidney,1.0), (signal intensity,was greater than,than kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed than in kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater than in kidney respectively,1.0), (signal intensity,was greater respectively in,tumor bed,1.0), (signal intensity,was greater At,2.5 h post-injection,1.0), (signal intensity,was,greater,1.0)][(signal intensity,was,greater in tumor bed than in kidney respectively,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed than in kidney respectively,1.0), (signal intensity,was,At 2.5 h post-injection greater than in kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed respectively,1.0), (signal intensity,was,greater in tumor bed than in kidney,1.0), (signal intensity,was,greater respectively,1.0), (signal intensity,was greater in,tumor bed,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed,1.0), (signal intensity,was greater respectively At,2.5 h post-injection,1.0), (signal intensity,was greater respectively than,than kidney,1.0), (signal intensity,was greater than,than kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed than in kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater than in kidney respectively,1.0), (signal intensity,was greater respectively in,tumor bed,1.0), (signal intensity,was greater At,2.5 h post-injection,1.0), (signal intensity,was,greater,1.0)][(signal intensity,was,greater in tumor bed than in kidney respectively,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed than in kidney respectively,1.0), (signal intensity,was,At 2.5 h post-injection greater than in kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed respectively,1.0), (signal intensity,was,greater in tumor bed than in kidney,1.0), (signal intensity,was,greater respectively,1.0), (signal intensity,was greater in,tumor bed,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed,1.0), (signal intensity,was greater respectively At,2.5 h post-injection,1.0), (signal intensity,was greater respectively than,than kidney,1.0), (signal intensity,was greater than,than kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed than in kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater than in kidney respectively,1.0), (signal intensity,was greater respectively in,tumor bed,1.0), (signal intensity,was greater At,2.5 h post-injection,1.0), (signal intensity,was,greater,1.0)][(signal intensity,was,greater in tumor bed than in kidney respectively,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed than in kidney respectively,1.0), (signal intensity,was,At 2.5 h post-injection greater than in kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed respectively,1.0), (signal intensity,was,greater in tumor bed than in kidney,1.0), (signal intensity,was,greater respectively,1.0), (signal intensity,was greater in,tumor bed,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed,1.0), (signal intensity,was greater respectively At,2.5 h post-injection,1.0), (signal intensity,was greater respectively than,than kidney,1.0), (signal intensity,was greater than,than kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed than in kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater than in kidney respectively,1.0), (signal intensity,was greater respectively in,tumor bed,1.0), (signal intensity,was greater At,2.5 h post-injection,1.0), (signal intensity,was,greater,1.0)][(signal intensity,was,greater in tumor bed than in kidney respectively,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed than in kidney respectively,1.0), (signal intensity,was,At 2.5 h post-injection greater than in kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed respectively,1.0), (signal intensity,was,greater in tumor bed than in kidney,1.0), (signal intensity,was,greater respectively,1.0), (signal intensity,was greater in,tumor bed,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed,1.0), (signal intensity,was greater respectively At,2.5 h post-injection,1.0), (signal intensity,was greater respectively than,than kidney,1.0), (signal intensity,was greater than,than kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed than in kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater than in kidney respectively,1.0), (signal intensity,was greater respectively in,tumor bed,1.0), (signal intensity,was greater At,2.5 h post-injection,1.0), (signal intensity,was,greater,1.0)][(signal intensity,was,greater in tumor bed than in kidney respectively,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed than in kidney respectively,1.0), (signal intensity,was,At 2.5 h post-injection greater than in kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed respectively,1.0), (signal intensity,was,greater in tumor bed than in kidney,1.0), (signal intensity,was,greater respectively,1.0), (signal intensity,was greater in,tumor bed,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed,1.0), (signal intensity,was greater respectively At,2.5 h post-injection,1.0), (signal intensity,was greater respectively than,than kidney,1.0), (signal intensity,was greater than,than kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed than in kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater than in kidney respectively,1.0), (signal intensity,was greater respectively in,tumor bed,1.0), (signal intensity,was greater At,2.5 h post-injection,1.0), (signal intensity,was,greater,1.0)][(signal intensity,was,greater in tumor bed than in kidney respectively,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed than in kidney respectively,1.0), (signal intensity,was,At 2.5 h post-injection greater than in kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed respectively,1.0), (signal intensity,was,greater in tumor bed than in kidney,1.0), (signal intensity,was,greater respectively,1.0), (signal intensity,was greater in,tumor bed,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed,1.0), (signal intensity,was greater respectively At,2.5 h post-injection,1.0), (signal intensity,was greater respectively than,than kidney,1.0), (signal intensity,was greater than,than kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed than in kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater than in kidney respectively,1.0), (signal intensity,was greater respectively in,tumor bed,1.0), (signal intensity,was greater At,2.5 h post-injection,1.0), (signal intensity,was,greater,1.0)][(signal intensity,was,greater in tumor bed than in kidney respectively,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed than in kidney respectively,1.0), (signal intensity,was,At 2.5 h post-injection greater than in kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed respectively,1.0), (signal intensity,was,greater in tumor bed than in kidney,1.0), (signal intensity,was,greater respectively,1.0), (signal intensity,was greater in,tumor bed,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed,1.0), (signal intensity,was greater respectively At,2.5 h post-injection,1.0), (signal intensity,was greater respectively than,than kidney,1.0), (signal intensity,was greater than,than kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater in tumor bed than in kidney,1.0), (signal intensity,was,At 2.5 h post-injection greater than in kidney respectively,1.0), (signal intensity,was greater respectively in,tumor bed,1.0), (signal intensity,was greater At,2.5 h post-injection,1.0), (signal intensity,was,greater,1.0)][(Fluorescence imaging ex vivo,confirmed,results,1.0)][(MSOT imaging,demonstrated,selective accumulation and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin,1.0), (MSOT imaging,provided,high-resolution images,1.0), (MSOT imaging,demonstrated,selective accumulation,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,provided,images,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation,1.0), (MSOT imaging,demonstrated,accumulation and,1.0), (MSOT imaging,demonstrated,accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin,1.0), (MSOT imaging,demonstrated,accumulation in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and,1.0)][(MSOT imaging,demonstrated,selective accumulation and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin,1.0), (MSOT imaging,provided,high-resolution images,1.0), (MSOT imaging,demonstrated,selective accumulation,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,provided,images,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation,1.0), (MSOT imaging,demonstrated,accumulation and,1.0), (MSOT imaging,demonstrated,accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin,1.0), (MSOT imaging,demonstrated,accumulation in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and,1.0)][(MSOT imaging,demonstrated,selective accumulation and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin,1.0), (MSOT imaging,provided,high-resolution images,1.0), (MSOT imaging,demonstrated,selective accumulation,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,provided,images,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation,1.0), (MSOT imaging,demonstrated,accumulation and,1.0), (MSOT imaging,demonstrated,accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin,1.0), (MSOT imaging,demonstrated,accumulation in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and,1.0)][(MSOT imaging,demonstrated,selective accumulation and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin,1.0), (MSOT imaging,provided,high-resolution images,1.0), (MSOT imaging,demonstrated,selective accumulation,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,provided,images,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation,1.0), (MSOT imaging,demonstrated,accumulation and,1.0), (MSOT imaging,demonstrated,accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin,1.0), (MSOT imaging,demonstrated,accumulation in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and,1.0)][(MSOT imaging,demonstrated,selective accumulation and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin,1.0), (MSOT imaging,provided,high-resolution images,1.0), (MSOT imaging,demonstrated,selective accumulation,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,provided,images,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation,1.0), (MSOT imaging,demonstrated,accumulation and,1.0), (MSOT imaging,demonstrated,accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin,1.0), (MSOT imaging,demonstrated,accumulation in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and,1.0)][(MSOT imaging,demonstrated,selective accumulation and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin,1.0), (MSOT imaging,provided,high-resolution images,1.0), (MSOT imaging,demonstrated,selective accumulation,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,provided,images,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation,1.0), (MSOT imaging,demonstrated,accumulation and,1.0), (MSOT imaging,demonstrated,accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin,1.0), (MSOT imaging,demonstrated,accumulation in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and,1.0)][(MSOT imaging,demonstrated,selective accumulation and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin,1.0), (MSOT imaging,provided,high-resolution images,1.0), (MSOT imaging,demonstrated,selective accumulation,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,provided,images,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation,1.0), (MSOT imaging,demonstrated,accumulation and,1.0), (MSOT imaging,demonstrated,accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin,1.0), (MSOT imaging,demonstrated,accumulation in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and,1.0)][(MSOT imaging,demonstrated,selective accumulation and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin,1.0), (MSOT imaging,provided,high-resolution images,1.0), (MSOT imaging,demonstrated,selective accumulation,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,provided,images,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation,1.0), (MSOT imaging,demonstrated,accumulation and,1.0), (MSOT imaging,demonstrated,accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin,1.0), (MSOT imaging,demonstrated,accumulation in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and,1.0)][(MSOT imaging,demonstrated,selective accumulation and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin,1.0), (MSOT imaging,provided,high-resolution images,1.0), (MSOT imaging,demonstrated,selective accumulation,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,provided,images,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation,1.0), (MSOT imaging,demonstrated,accumulation and,1.0), (MSOT imaging,demonstrated,accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin,1.0), (MSOT imaging,demonstrated,accumulation in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and,1.0)][(MSOT imaging,demonstrated,selective accumulation and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin,1.0), (MSOT imaging,provided,high-resolution images,1.0), (MSOT imaging,demonstrated,selective accumulation,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,provided,images,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation,1.0), (MSOT imaging,demonstrated,accumulation and,1.0), (MSOT imaging,demonstrated,accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin,1.0), (MSOT imaging,demonstrated,accumulation in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and,1.0)][(MSOT imaging,demonstrated,selective accumulation and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin,1.0), (MSOT imaging,provided,high-resolution images,1.0), (MSOT imaging,demonstrated,selective accumulation,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,provided,images,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation,1.0), (MSOT imaging,demonstrated,accumulation and,1.0), (MSOT imaging,demonstrated,accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin,1.0), (MSOT imaging,demonstrated,accumulation in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and,1.0)][(MSOT imaging,demonstrated,selective accumulation and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin,1.0), (MSOT imaging,provided,high-resolution images,1.0), (MSOT imaging,demonstrated,selective accumulation,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,provided,images,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation,1.0), (MSOT imaging,demonstrated,accumulation and,1.0), (MSOT imaging,demonstrated,accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin,1.0), (MSOT imaging,demonstrated,accumulation in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and,1.0)][(MSOT imaging,demonstrated,selective accumulation and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin,1.0), (MSOT imaging,provided,high-resolution images,1.0), (MSOT imaging,demonstrated,selective accumulation,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,provided,images,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation,1.0), (MSOT imaging,demonstrated,accumulation and,1.0), (MSOT imaging,demonstrated,accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin,1.0), (MSOT imaging,demonstrated,accumulation in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and,1.0)][(MSOT imaging,demonstrated,selective accumulation and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin,1.0), (MSOT imaging,provided,high-resolution images,1.0), (MSOT imaging,demonstrated,selective accumulation,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,provided,images,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation,1.0), (MSOT imaging,demonstrated,accumulation and,1.0), (MSOT imaging,demonstrated,accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin,1.0), (MSOT imaging,demonstrated,accumulation in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and,1.0)][(MSOT imaging,demonstrated,selective accumulation and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin,1.0), (MSOT imaging,provided,high-resolution images,1.0), (MSOT imaging,demonstrated,selective accumulation,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,provided,images,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation,1.0), (MSOT imaging,demonstrated,accumulation and,1.0), (MSOT imaging,demonstrated,accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin,1.0), (MSOT imaging,demonstrated,accumulation in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and,1.0)][(MSOT imaging,demonstrated,selective accumulation and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin,1.0), (MSOT imaging,provided,high-resolution images,1.0), (MSOT imaging,demonstrated,selective accumulation,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,provided,images,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation,1.0), (MSOT imaging,demonstrated,accumulation and,1.0), (MSOT imaging,demonstrated,accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin,1.0), (MSOT imaging,demonstrated,accumulation in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and,1.0)][(MSOT imaging,demonstrated,selective accumulation and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin,1.0), (MSOT imaging,provided,high-resolution images,1.0), (MSOT imaging,demonstrated,selective accumulation,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,provided,images,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation,1.0), (MSOT imaging,demonstrated,accumulation and,1.0), (MSOT imaging,demonstrated,accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin,1.0), (MSOT imaging,demonstrated,accumulation in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and,1.0)][(MSOT imaging,demonstrated,selective accumulation and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin,1.0), (MSOT imaging,provided,high-resolution images,1.0), (MSOT imaging,demonstrated,selective accumulation,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,provided,images,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation,1.0), (MSOT imaging,demonstrated,accumulation and,1.0), (MSOT imaging,demonstrated,accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin,1.0), (MSOT imaging,demonstrated,accumulation in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and,1.0)][(MSOT imaging,demonstrated,selective accumulation and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin,1.0), (MSOT imaging,provided,high-resolution images,1.0), (MSOT imaging,demonstrated,selective accumulation,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,provided,images,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation,1.0), (MSOT imaging,demonstrated,accumulation and,1.0), (MSOT imaging,demonstrated,accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin,1.0), (MSOT imaging,demonstrated,accumulation in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and,1.0)][(MSOT imaging,demonstrated,selective accumulation and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin,1.0), (MSOT imaging,provided,high-resolution images,1.0), (MSOT imaging,demonstrated,selective accumulation,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,provided,images,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation,1.0), (MSOT imaging,demonstrated,accumulation and,1.0), (MSOT imaging,demonstrated,accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin,1.0), (MSOT imaging,demonstrated,accumulation in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and,1.0)][(MSOT imaging,demonstrated,selective accumulation and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin,1.0), (MSOT imaging,provided,high-resolution images,1.0), (MSOT imaging,demonstrated,selective accumulation,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,provided,images,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation,1.0), (MSOT imaging,demonstrated,accumulation and,1.0), (MSOT imaging,demonstrated,accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin,1.0), (MSOT imaging,demonstrated,accumulation in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and,1.0)][(MSOT imaging,demonstrated,selective accumulation and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin,1.0), (MSOT imaging,provided,high-resolution images,1.0), (MSOT imaging,demonstrated,selective accumulation,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,provided,images,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation,1.0), (MSOT imaging,demonstrated,accumulation and,1.0), (MSOT imaging,demonstrated,accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin,1.0), (MSOT imaging,demonstrated,accumulation in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and,1.0)][(MSOT imaging,demonstrated,selective accumulation and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin,1.0), (MSOT imaging,provided,high-resolution images,1.0), (MSOT imaging,demonstrated,selective accumulation,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,provided,images,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation,1.0), (MSOT imaging,demonstrated,accumulation and,1.0), (MSOT imaging,demonstrated,accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin,1.0), (MSOT imaging,demonstrated,accumulation in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and,1.0)][(MSOT imaging,demonstrated,selective accumulation and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin,1.0), (MSOT imaging,provided,high-resolution images,1.0), (MSOT imaging,demonstrated,selective accumulation,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,provided,images,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation,1.0), (MSOT imaging,demonstrated,accumulation and,1.0), (MSOT imaging,demonstrated,accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin,1.0), (MSOT imaging,demonstrated,accumulation in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and,1.0)][(MSOT imaging,demonstrated,selective accumulation and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin,1.0), (MSOT imaging,provided,high-resolution images,1.0), (MSOT imaging,demonstrated,selective accumulation,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,provided,images,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation,1.0), (MSOT imaging,demonstrated,accumulation and,1.0), (MSOT imaging,demonstrated,accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin,1.0), (MSOT imaging,demonstrated,accumulation in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and,1.0)][(MSOT imaging,demonstrated,selective accumulation and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin,1.0), (MSOT imaging,provided,high-resolution images,1.0), (MSOT imaging,demonstrated,selective accumulation,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,provided,images,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation,1.0), (MSOT imaging,demonstrated,accumulation and,1.0), (MSOT imaging,demonstrated,accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin,1.0), (MSOT imaging,demonstrated,accumulation in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and,1.0)][(MSOT imaging,demonstrated,selective accumulation and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin,1.0), (MSOT imaging,provided,high-resolution images,1.0), (MSOT imaging,demonstrated,selective accumulation,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,provided,images,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation,1.0), (MSOT imaging,demonstrated,accumulation and,1.0), (MSOT imaging,demonstrated,accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin,1.0), (MSOT imaging,demonstrated,accumulation in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and,1.0)][(MSOT imaging,demonstrated,selective accumulation and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin,1.0), (MSOT imaging,provided,high-resolution images,1.0), (MSOT imaging,demonstrated,selective accumulation,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,provided,images,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation,1.0), (MSOT imaging,demonstrated,accumulation and,1.0), (MSOT imaging,demonstrated,accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin,1.0), (MSOT imaging,demonstrated,accumulation in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and,1.0)][(MSOT imaging,demonstrated,selective accumulation and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin,1.0), (MSOT imaging,provided,high-resolution images,1.0), (MSOT imaging,demonstrated,selective accumulation,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,provided,images,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation,1.0), (MSOT imaging,demonstrated,accumulation and,1.0), (MSOT imaging,demonstrated,accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin,1.0), (MSOT imaging,demonstrated,accumulation in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and,1.0)][(MSOT imaging,demonstrated,selective accumulation and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin,1.0), (MSOT imaging,provided,high-resolution images,1.0), (MSOT imaging,demonstrated,selective accumulation,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,provided,images,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation,1.0), (MSOT imaging,demonstrated,accumulation and,1.0), (MSOT imaging,demonstrated,accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin,1.0), (MSOT imaging,demonstrated,accumulation in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and,1.0)][(MSOT imaging,demonstrated,selective accumulation and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin,1.0), (MSOT imaging,provided,high-resolution images,1.0), (MSOT imaging,demonstrated,selective accumulation,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,provided,images,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation,1.0), (MSOT imaging,demonstrated,accumulation and,1.0), (MSOT imaging,demonstrated,accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin,1.0), (MSOT imaging,demonstrated,accumulation in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and,1.0)][(MSOT imaging,demonstrated,selective accumulation and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin,1.0), (MSOT imaging,provided,high-resolution images,1.0), (MSOT imaging,demonstrated,selective accumulation,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and in vivo,1.0), (MSOT imaging,provided,images,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation,1.0), (MSOT imaging,demonstrated,accumulation and,1.0), (MSOT imaging,demonstrated,accumulation and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin,1.0), (MSOT imaging,demonstrated,accumulation in vitro and,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and in vivo,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin and,1.0), (MSOT imaging,demonstrated,selective accumulation of fluorescent osteopontin in vitro and in vivo,1.0), (MSOT imaging,demonstrated,accumulation of fluorescent osteopontin in vitro and,1.0), (MSOT imaging,demonstrated,accumulation of osteopontin,1.0), (MSOT imaging,demonstrated,selective accumulation in vitro and,1.0)][(Further development,is promising for,imaging,1.0), (development,is promising for,advanced imaging,1.0), (Further development,is promising for,advanced imaging,1.0), (development,is promising for,diagnostic imaging,1.0), (Further development,is promising for,advanced diagnostic imaging,1.0), (development,is promising for,imaging,1.0), (development,is promising for,advanced diagnostic imaging,1.0), (Further development,is promising for,diagnostic imaging,1.0)][(Further development,is promising for,imaging,1.0), (development,is promising for,advanced imaging,1.0), (Further development,is promising for,advanced imaging,1.0), (development,is promising for,diagnostic imaging,1.0), (Further development,is promising for,advanced diagnostic imaging,1.0), (development,is promising for,imaging,1.0), (development,is promising for,advanced diagnostic imaging,1.0), (Further development,is promising for,diagnostic imaging,1.0)][(Further development,is promising for,imaging,1.0), (development,is promising for,advanced imaging,1.0), (Further development,is promising for,advanced imaging,1.0), (development,is promising for,diagnostic imaging,1.0), (Further development,is promising for,advanced diagnostic imaging,1.0), (development,is promising for,imaging,1.0), (development,is promising for,advanced diagnostic imaging,1.0), (Further development,is promising for,diagnostic imaging,1.0)][(Further development,is promising for,imaging,1.0), (development,is promising for,advanced imaging,1.0), (Further development,is promising for,advanced imaging,1.0), (development,is promising for,diagnostic imaging,1.0), (Further development,is promising for,advanced diagnostic imaging,1.0), (development,is promising for,imaging,1.0), (development,is promising for,advanced diagnostic imaging,1.0), (Further development,is promising for,diagnostic imaging,1.0)][(Further development,is promising for,imaging,1.0), (development,is promising for,advanced imaging,1.0), (Further development,is promising for,advanced imaging,1.0), (development,is promising for,diagnostic imaging,1.0), (Further development,is promising for,advanced diagnostic imaging,1.0), (development,is promising for,imaging,1.0), (development,is promising for,advanced diagnostic imaging,1.0), (Further development,is promising for,diagnostic imaging,1.0)][(Further development,is promising for,imaging,1.0), (development,is promising for,advanced imaging,1.0), (Further development,is promising for,advanced imaging,1.0), (development,is promising for,diagnostic imaging,1.0), (Further development,is promising for,advanced diagnostic imaging,1.0), (development,is promising for,imaging,1.0), (development,is promising for,advanced diagnostic imaging,1.0), (Further development,is promising for,diagnostic imaging,1.0)][(Further development,is promising for,imaging,1.0), (development,is promising for,advanced imaging,1.0), (Further development,is promising for,advanced imaging,1.0), (development,is promising for,diagnostic imaging,1.0), (Further development,is promising for,advanced diagnostic imaging,1.0), (development,is promising for,imaging,1.0), (development,is promising for,advanced diagnostic imaging,1.0), (Further development,is promising for,diagnostic imaging,1.0)][(Further development,is promising for,imaging,1.0), (development,is promising for,advanced imaging,1.0), (Further development,is promising for,advanced imaging,1.0), (development,is promising for,diagnostic imaging,1.0), (Further development,is promising for,advanced diagnostic imaging,1.0), (development,is promising for,imaging,1.0), (development,is promising for,advanced diagnostic imaging,1.0), (Further development,is promising for,diagnostic imaging,1.0)]